Ramírez-Torres A, Hérnandez-Contreras M, Almela-Mendoza R, Muñoz-Cabello R, Aguilar-Orduño E, Hernández-Aragón F

Language: Spanish
References: 32
Page: 263-266
PDF size: 169.92 Kb.

ABSTRACT

Introduction: pigmented villonodular synovitis (PVNS) is a benign condition that affects the knee, leading to abnormal proliferation of the synovial membrane and the accumulation of hemosiderin in the joint cavity. Although it can be surgically treated, PVNS tends to have a high recurrence rate, potentially resulting in chronic joint damage. Case report: we present the case of a young woman who experienced localized pain in her right knee due to a recurrence of PVNS. Magnetic resonance imaging revealed multiple multilobulated cystic lesions affecting the entire joint, including the ligaments. The patient underwent open surgical resection with a favorable clinical outcome. Histopathological examinations confirmed the absence of malignancy. Conclusion: while arthroscopy is typically the preferred treatment for PVNS, this case highlights the tendency for recurrence associated with this approach. Open surgical resection, supported by benign histopathological findings in this case, suggests a favorable long-term prognosis.

REFERENCES

1. Robert M, Farese H, Miossec P. Update on tenosynovial giant cell tumor, an inflammatory arthritis with neoplastic features. Front Immunol. 2022; 13(12): 1-11.

2. Gouin F, Noailles T. Localized and diffuse forms of tenosynovial giant cell tumor (formerly giant cell tumor of the tendon sheath and pigmented villonodular synovitis). Orthop Traumatol Surg Res. 2017; 103(1S): S91-7.

3. Farese H, Noack M, Miossec P. Synoviocytes from pigmented villonodular synovitis are less sensitive to cadmium-induced cell death than synoviocytes from rheumatoid arthritis. Sci Rep. 2022; 12(1): 1-13.

4. Report of the World Health Organization technical consultation on prevention and control of iron deficiency in infants and young children in malaria-endemic areas, Lyon, France, 12-14 June 2006. Food Nutr Bull. 2007; 28: S489-S631.

5. Ehrenstein V, Andersen SL, Qazi I, Sankar N, Pedersen AB, Sikorski R, et al. Tenosynovial giant cell tumor: incidence, prevalence, patient characteristics, and recurrence. A registry-based cohort study in Denmark. J Rheumatol. 2017; 44: 1476-83.

6. Osanai T, Suzuki H, Hiraga H, Soma T, Nojima T. Extra-articular diffuse-type tenosynovial giant cell tumor with benign histological features resulting in fatal pulmonary metastases. J Orthop Surg (Hong Kong). 2017; 25(1): 2309499017690323.

7. Xie GP, Jiang N, Liang CX, Zeng JC, Chen ZY, Xu Q, et al. Pigmented villonodular synovitis: a retrospective multicenter study of 237 cases. PLoS One. 2015; 10(3): e0121451.

8. Kager M, Kager R, Fa?ek P, Fa?ek A, Szczypiór G, Niemunis-Sawicka J, et al. Tenosynovial giant cell tumor. Folia Med Cracov. 2022; 62(2): 93-107.

9. Bernthal NM, Ishmael CR, Burke ZDC. Management of pigmented villonodular synovitis (PVNS): an Orthopedic Surgeon's perspective. Curr Oncol Rep. 2020; 22(6): 63.

10. Healey JH, Bernthal NM, van de Sande M. Management of tenosynovial giant cell tumor: a neoplastic and inflammatory disease. J Am Acad Orthop Surg Glob Res Rev. 2020; 4(11): e20.00028.

11. Capellen CF, Tiling R, Klein A, Baur-Melnyk A, Knosel T, Birkenmaier C, et al. Lowering the recurrence rate in pigmented villonodular synovitis: a series of 120 resections. Rheumatology (Oxford). 2018; 57(8): 1448-52.

12. Xu C, Guo H, Bell KL, Kuo FC, Chen JY. Pigmented villonodular synovitis does not influence the outcome following cementless total hip arthroplasty using ceramic-on-ceramic articulation: a case-control study with middle-term follow-up. J Orthop Surg Res. 2018; 13(1): 294.

13. Willimon SC, Schrader T, Perkins CA. Arthroscopic management of pigmented villonodular synovitis of the hip in children and adolescents. Orthop J Sports Med. 2018; 6(3): 2325967118763118.

14. Heng H, Li D, Su W, Liu X, Yu D, Bian Z, et al. Exploration of comorbidity mechanisms and potential therapeutic targets of rheumatoid arthritis and pigmented villonodular synovitis using machine learning and bioinformatics analysis. Front Genet. 2023; 13: 1095058.

15. Ansel S, Yan X, Chong P, Lo S, McCleery M, Mahendra A, et al. Tenosynovial giant cell tumor: a case report. J Med Case Rep. 2023; 17(1): 419.

16. Jendrissek KA, Hotfiel T, Swoboda B, Soder S, Janka R. Pigmented villonodular synovitis. A rare differential diagnosis of synovial joint swelling. Z Rheumatol. 2016; 75(2): 157-65.

17. Tu NV, Quyen NVS, Ngoc MH, Trung HP, Nguyen BS, Trung DT. Tenosynovial giant cell tumor of cruciate ligament: A case report and review. Int J Surg Case Rep. 2022; 91: 106771.

18. Song HQ, Wu GF, Qi WZ, Lin LJ. Diffuse pigmented villonodular synovitis treated with arthroscopic total synovial peel. BMC Surg. 2023; 23(1): 12.

19. Kerschner A, King D, Vetter C. Clinical outcomes of diffuse PVNS of the knee following arthroscopic complete synovectomy±posterior open resection. J Orthop. 2021; 28: 34-40.

20. Pinto AA, Krishnan R, Shekar KY, Amaravathi RS. A novel technique of resecting localized pigmented villonodular synovitis of the knee joint. J Orthop Case Rep. 2023; 13(9): 18-21.

21. Firoozabadi MA, Mortazavi SMJ, Toofan H, Khalili M, Shariyate MJ. Black discoloration of the knee articular cartilage in a patient with pigmented villonodular synovitis: A case report. Clin Case Rep. 2023; 11(9): e7894.

22. Hoa DH, Ngoc DV, Chau NM, Ninh TP, Sang NV, Long VT. Pigmented villonodular synovitis of the knee in a child: a case report. Radiol Case Rep. 2022; 17(5): 1798-802.

23. Lynskey SJ, Pianta MJ. MRI and thallium features of pigmented villonodular synovitis and giant cell tumours of tendon sheaths: a retrospective single centre study of imaging and literature review. Br J Radiol. 2015; 88(1056): 20150528.

24. Stacchiotti S, Dürr HR, Schaefer IM, Woertler K, Haas R, Trama A, et al. Best clinical management of tenosynovial giant cell tumour (TGCT): a consensus paper from the community of experts. Cancer Treat Rev. 2023; 112: 102491.

25. Lau SCX, Lim LZ, Hallinan JTPD, Makmur A. Incidental findings involving the temporomandibular joint on computed tomography and magnetic resonance imaging. Singapore Med J. 2023; 64(4): 262-270.

26. Jaffe HL, Lichtenstein L, Sutro CJ. Pigmented villonodular synovitis, bursitis, and tenosynovitis: a discussion of the synovial and bursal equivalents of tenosynovial lesion commonly denoted as xanthoma, xanthogranuloma, giant cell tumor or myeloplaxoma of tendon sheath with some consideration of this tendon sheath lesion itself. Arch Pathol. 1941, 31: 731-65.

27. Fang Y, Zhang Q. Recurrence of pigmented villonodular synovitis of the knee: A case report with review of literature on the risk factors causing recurrence. Medicine (Baltimore). 2020; 99(16): 19856.

28. Li T, Mei L, Xu Y, Cao Y, Shi X, Chen G, et al. Total hip arthroplasty or arthroscopy for pigmented villonodular synovitis of the hip: a retrospective study with 3?year follow?up at minimum. Orthop Surg. 2023; 15(6): 1498-504.

29. Sun W, Mao Y, Xiong Y, Li J. The clinical effect of topical application of tranexamic acid in arthroscopic synovectomy of pigmented villonodular synovitis of the knee. Orthopedics. 2023; 46(3): E179-85.

30. Lavignac P, Herraudet P, Baudelle F, Commeil P, Legallois Y, Fabre T. Arthroscopic treatment of diffuse pigmented villonodular synovitis of the elbow. Orthop Traumatol Surg Res. 2023; 109(5): 103493.

31. Moran J, Miller MD, Schneble CA, Yalcin S, Katz LD, Medvecky MJ. Arthroscopic synovectomy for tenosynovial giant cell tumor/pigmented villonodular synovitis in the posterior knee using the posterior trans-septal portal technique. JBJS Essent Surg Tech. 2022; 12(1): e21.00051.

32. Noailles T, Brulefert K, Briand S, Longis PM, Andrieu K, Chalopin A, et al. Giant cell tumor of tendon sheath: open surgery or arthroscopic synovectomy? A systematic review of the literature. Orthop Traumatol Surg Res. 2017; 103(5): 809-14.